Figure.2.

The clinical significance and accuracy verification of CTAs in different cohorts and subgroups. Survival analysis of CTAs in HCC patients in training cohort (A), ICGC validation cohort (B), TCGA validation cohort (C), different AFP groups (J), and different BCLC stages (K). (D, E, F) Time-dependent ROC analysis of CTAs signature used to predict 1-, 2- and 3-year survival rates in the training, ICGC and TCGA cohort. (G, H, I) ROC curves of CTA signatures and other clinicopathological indicators in training, ICGC and TCGA cohorts.